TTIs occur primarily through the transfusion of contaminated blood components. This can happen due to asymptomatic carriers, window periods where the pathogen is not detectable, or errors in screening and testing. The risk is influenced by the prevalence of the pathogen in the donor population and the effectiveness of the blood safety protocols in place.
